Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

43 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Crohn's disease.
Roda G, Chien Ng S, Kotze PG, Argollo M, Panaccione R, Spinelli A, Kaser A, Peyrin-Biroulet L, Danese S. Roda G, et al. Among authors: argollo m. Nat Rev Dis Primers. 2020 Apr 2;6(1):22. doi: 10.1038/s41572-020-0156-2. Nat Rev Dis Primers. 2020. PMID: 32242028 Review.
Novel therapeutic targets for inflammatory bowel disease.
Argollo M, Fiorino G, Hindryckx P, Peyrin-Biroulet L, Danese S. Argollo M, et al. J Autoimmun. 2017 Dec;85:103-116. doi: 10.1016/j.jaut.2017.07.004. Epub 2017 Jul 12. J Autoimmun. 2017. PMID: 28711286 Review.
Vedolizumab for the treatment of Crohn's disease.
Argollo M, Fiorino G, Peyrin-Biroulet L, Danese S. Argollo M, et al. Expert Rev Clin Immunol. 2018 Mar;14(3):179-189. doi: 10.1080/1744666X.2018.1438189. Epub 2018 Feb 23. Expert Rev Clin Immunol. 2018. PMID: 29406811 Review.
Loss of Response to Vedolizumab and Ability of Dose Intensification to Restore Response in Patients With Crohn's Disease or Ulcerative Colitis: A Systematic Review and Meta-analysis.
Peyrin-Biroulet L, Danese S, Argollo M, Pouillon L, Peppas S, Gonzalez-Lorenzo M, Lytras T, Bonovas S. Peyrin-Biroulet L, et al. Among authors: argollo m. Clin Gastroenterol Hepatol. 2019 Apr;17(5):838-846.e2. doi: 10.1016/j.cgh.2018.06.026. Epub 2018 Jun 20. Clin Gastroenterol Hepatol. 2019. PMID: 29935327
PF-00547659 for the treatment of Crohn's disease and ulcerative colitis.
Allocca M, Gilardi D, Fiorino G, Furfaro F, Argollo M, Peyrin-Biroulet L, Danese S. Allocca M, et al. Among authors: argollo m. Expert Opin Investig Drugs. 2018 Jul;27(7):623-629. doi: 10.1080/13543784.2018.1494722. Epub 2018 Jul 16. Expert Opin Investig Drugs. 2018. PMID: 29985060 Review.
The impact of biologics in surgical outcomes in ulcerative colitis.
Argollo MC, Kotze PG, Spinelli A, Gomes TNF, Danese S. Argollo MC, et al. Best Pract Res Clin Gastroenterol. 2018 Feb-Apr;32-33:79-87. doi: 10.1016/j.bpg.2018.05.014. Epub 2018 Jun 8. Best Pract Res Clin Gastroenterol. 2018. PMID: 30060942 Review.
Biosimilars of adalimumab: the upcoming challenge in IBD.
Fiorino G, Gilardi D, Correale C, Furfaro F, Roda G, Loy L, Argollo M, Allocca M, Peyrin-Biroulet L, Danese S. Fiorino G, et al. Among authors: argollo m. Expert Opin Biol Ther. 2019 Oct;19(10):1023-1030. doi: 10.1080/14712598.2019.1564033. Epub 2019 Jan 8. Expert Opin Biol Ther. 2019. PMID: 30601098 Review.
43 results